New Medication Trogarzo Approved for Drug-Resistant HIV
TUESDAY, March 6, 2018 -- Trogarzo (ibalizumab-uiyk) has been approved by the U.S. Food and Drug Administration to treat AIDS-causing HIV that has not responded to other antiretroviral medications.
Trogarzo is given intravenously once every 14 days in combination with other antiretroviral drugs, the FDA said Tuesday in a news release.
"While most patients living with HIV can be successfully treated using a combination of two or more antiretroviral drugs, a small percentage of patients who have taken many HIV drugs in the past have multidrug resistant HIV, limiting their treatment options," said Dr. Jeff Murray, deputy director of the agency's Division of Antiviral Products.
"Trogarzo is the first drug in a new class of antiretroviral medications that can provide significant benefit to patients who have run out of HIV treatment options," Murray added.
Trogarzo was evaluated in clinical studies involving 40 people who continued to have high blood levels of HIV, despite use of antiretroviral drugs. After 24 weeks of Trogarzo and other drugs, 43 percent of trial participants achieved HIV suppression, the FDA said.
The most common adverse reactions to Trogarzo were diarrhea, dizziness, nausea and rash. More severe side effects included immune system abnormalities.
Trogarzo is produced by TaiMed Biologics, based in Taiwan.
© 2020 HealthDay. All rights reserved.
Posted: March 2018
Read this next
THURSDAY, Sept. 10, 2020 -- The daily drug regimen known as PrEP is a nearly foolproof way to prevent HIV infection. But a new study suggests that many high-risk Americans may be...
THURSDAY, Aug. 27, 2020 -- The daily use of antiretroviral meds to help prevent HIV infection has been around for a few years now -- it's called pre-exposure prophylaxis, or...
WEDNESDAY, Aug. 26, 2020 -- HIV researchers have long known that in rare cases, patients can naturally suppress the virus without taking medication. Now, a new study offers...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.